Drug Research
New BioAccelerator Expands Biomanufacturing Capacity for Canada
The Governments of Canada and Prince Edward Island (PEI) will invest $50 million in the BioAccelerator, the largest single investment in economic development infrastructure in PEI history.
The announcement was made by Ginette Petitpas Taylor, Minister of Official Languages, who...
Drug Research
BioMed X Launches New T Cell Immunology Discovery Platform
BioMed X unveiled its new immunology discovery platform designed to allow for the accurate and fast identification of target antigens of human T cell receptors (TCRs).
The platform is expected to be deployed via a collaborative model with pharmaceutical and...
Drug Research
Lonza Completes Expansion of Conjugation Facility in Visp
Lonza, a partner to the pharmaceutical, biotech and nutraceutical markets, has completed a planned expansion of its bioconjugation facility in Visp, Switzerland.
The expansion includes two manufacturing suites and supporting infrastructure to support an extended customer portfolio, including companies entering...
IT & Data Management
Australia Creates First In The World Biotech ESG Guidance
A group of committed AusBiotech leaders has joined forces to create an Australian biotech first: a sector-specific environmental, social, and governance (ESG) tool in order to assist companies in attracting investment and navigating ESG reporting.
The AusBiotech ESG Working Group...
Clinical Trials
Long Term Survival In Lung Cancer Can Be A Possibility
Final assessments of a Phase II trial for resectable non-small cell lung cancer found that 60% of patients who had gone on to receive the neoadjuvant nivolumab remained recurrence-free five years following surgery. Overall survival rates were also found...
News
Three Novel Ways Tested By CMS To Lower The Cost of Drugs
It has come to light that the federal health agencies have gone on to select three new models so as to lower the prices of the drugs and work on President Joe Biden’s executive order that targets the drug...
Clinical Trials
Clinical Trials Diversity Continues To Be Area To Watch For
Biopharma companies as well as policymakers know the significance of assessing medical and drug products across a broad range of racial and ethnic universes so as to fully comprehend the medical effects on patients. This has indeed pushed the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read